Experience of perampanel monotherapy beyond initial titration to achieve seizure freedom in patients with focal‐onset seizures with newly diagnosed or currently untreated recurrent epilepsy: A post hoc analysis of the open‐label Study 342 (FREEDOM)

OBJECTIVE: This post hoc analysis evaluated whether continued treatment with perampanel monotherapy beyond initial titration may be appropriate for patients with focal‐onset seizures (FOS) with currently untreated epilepsy to achieve seizure freedom with an effective dose. METHODS: Study 342 (NCT032...

Descripción completa

Detalles Bibliográficos
Autores principales: Husni, Ryan Edbert, Ngo, Leock Y., Senokuchi, Hirofumi, Patten, Anna, Hiramatsu, Hidetaka, Watanabe, Kazuaki, Yamamoto, Takamichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886102/
https://www.ncbi.nlm.nih.gov/pubmed/34657389
http://dx.doi.org/10.1002/epi4.12551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886102/
https://www.ncbi.nlm.nih.gov/pubmed/34657389
http://dx.doi.org/10.1002/epi4.12551

Ejemplares similares